Autolus Therapeutics Stock Story
| AUTL Stock | USD 4.48 0.08 1.75% |
About 54% of Autolus Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Autolus Therapeutics suggests that many traders are impartial. Autolus Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Autolus Therapeutics. The current market sentiment, together with Autolus Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Autolus Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Autolus Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Autolus daily returns and investor perception about the current price of Autolus Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Autolus |
Requested story not found. it has been either deleted or moved. View all stories for Autolus Therapeutics.
Autolus Therapeutics Latest Timeline
Autolus Therapeutics is listed for 4.48. About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.2. Autolus Therapeutics had not issued any dividends in recent years.Check out Autolus Therapeutics Hype Analysis, Autolus Therapeutics Correlation and Autolus Therapeutics Performance. For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Autolus Stock analysis
When running Autolus Therapeutics' price analysis, check to measure Autolus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autolus Therapeutics is operating at the current time. Most of Autolus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Autolus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autolus Therapeutics' price. Additionally, you may evaluate how the addition of Autolus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Autolus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autolus Therapeutics. If investors know Autolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Autolus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.20) | Revenue Per Share 0.01 | Quarterly Revenue Growth (1.00) | Return On Assets (0.25) | Return On Equity (1.02) |
The market value of Autolus Therapeutics is measured differently than its book value, which is the value of Autolus that is recorded on the company's balance sheet. Investors also form their own opinion of Autolus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Autolus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autolus Therapeutics' market value can be influenced by many factors that don't directly affect Autolus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Autolus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Autolus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Autolus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.